[Management of hyperlipidemia caused by antihypertensive therapy].
Nakamura
K
K
Second Department of Internal Medicine, Toho University School of Medicine.
Nagai
Y
Y
Kagesawa
M
M
Nishihara
M
M
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000178:diet therapy; D006973:Hypertension / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics